This country profile provides an overview of Liberia’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 62/100
Overall rank: 9th

Treatment coverage

Lymphatic filariasis
74%
Onchocerciasis
74%
Schistosomiasis
31%
STH
90%
Trachoma
N/A
2.5 million people received treatment in Liberia in 2016 460,000 people in need did not receive treatment in Liberia in 2016

Liberia recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely date to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

⬆️ Treatment coverage increased from 61% in 2015 to 74% in 2016.

People needing treatment
2.71m
People receiving treatment
2.01m

Onchocerciasis

⬆️ Treatment coverage increased from 60% in 2015 to 74% in 2016.

People needing treatment
2.91m
People receiving treatment
2.15m

Schistosomiasis

⬆️ Treatment coverage increased from 0% in 2015 to 31% in 2016.

School-aged children needing treatment
537,000
School-aged children receiving treatment
168,000

Soil-transmitted helminths

⬆️ Treatment coverage increased from 27% in 2015 to 90% in 2016.

Pre-sch and school-aged children needing treatment
844,000
Pre-school and school-aged children receiving treatment
757,000

Trachoma

Liberia does not require mass treatment for trachoma.